Phase I Clinical Trial of Systemically Administered TUSC2(FUS1)-Nanoparticles Mediating Functional Gene Transfer in Humans-Reference-Cited by-同舟云学术

Phase I Clinical Trial of Systemically Administered TUSC2(FUS1)-Nanoparticles Mediating Functional Gene Transfer in Humans

Published:2012-04-25 Issue:4 Volume:7 Page:e34833
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Lu Charles,Stewart David J.,Lee J. Jack,Ji Lin,Ramesh Rajagopal,Jayachandran Gitanjali,Nunez Maria I.,Wistuba Ignacio I.,Erasmus Jeremy J.,Hicks Marshall E.,Grimm Elizabeth A.,Reuben James M.,Baladandayuthapani Veerabhadran,Templeton Nancy S.,McMannis John D.,Roth Jack A.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference34 articles.

1. Molecular themes in oncogenesis.;J Bishop;Cell,1991

2. Intrinsic tumour suppression.;S Lowe;Nature,2004

3. Adenovirus p53 gene therapy.;J Roth;Expert Opin Biol Ther,2006

4. Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer.;S Swisher;J Natl Cancer Inst,1999

5. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer.;J Roth;Nat Med,1996

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing the potential of hydrogels for advanced therapeutic applications: current achievements and future directions;Signal Transduction and Targeted Therapy;2024-07-01

2. Immunohistochemical and molecular evaluation of TUSC2 expression in breast cancer;Molecular Biology Reports;2024-03-06

3. Delivery of Interferon β-Encoding Plasmid via Lipid Nanoparticle Restores Interferon β Expression to Enhance Antitumor Immunity in Colon Cancer;ACS Nano;2024-02-06

4. Recent progress in drug delivery systems for tyrosine kinase inhibitors in the treatment of lung cancer;International Journal of Pharmaceutics;2024-01

5. Dendrimer-based nanomedicines for cancer immunotherapy;Nanomedicine in Cancer Immunotherapy;2024